Drug Type Radiopharmaceuticals and diagnostic agent, Radionuclide Drug Conjugates (RDC) |
Synonyms- |
Target |
Action inhibitors |
Mechanism GPC3 inhibitors(Glypican-3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Clinical | China | 16 Apr 2025 | |
Hepatocellular Carcinoma | Clinical | China | 16 Apr 2025 | |
Hepatocellular Carcinoma | Clinical | China | 16 Apr 2025 |